OR Scheduling Optimization Technology 2026 — PatSnap Eureka
Operating Room Scheduling Optimization: Patent & Innovation Landscape
From foundational constraint-based systems in 1997 to AI-driven, sensor-fused real-time rescheduling platforms in 2025, OR scheduling optimization has become one of the most active frontiers in healthcare operations technology. This report maps the patent and literature landscape across mathematical programming, metaheuristics, machine learning, and stochastic uncertainty frameworks.
A Canonical NP-Hard Problem Across Five Sub-Domains
Operating room scheduling optimization encompasses the full lifecycle of surgical planning: case-mix planning (CMP), master surgical scheduling (MSS), advance scheduling of elective patients, real-time intraoperative monitoring, and post-operative rescheduling. The field addresses a combinatorial optimization problem requiring simultaneous allocation of operating rooms, surgeons, anesthetists, nurses, surgical instruments, and downstream units such as intensive care units (ICUs), post-anesthesia care units (PACUs), and hospital beds.
The problem is further complicated by stochastic surgery durations, emergency patient arrivals, shared resources across ORs, and the interdependency of perioperative stages. As documented by WHO and reinforced by operational research literature, surgical services represent one of the most resource-intensive and cost-critical processes in hospital systems globally. Research from NIH underscores the downstream impact of OR inefficiency on patient outcomes and system capacity. The PatSnap Analytics platform enables IP teams to track innovation signals across all five sub-domains simultaneously.
Five core sub-domains characterize the innovation landscape: mathematical programming models (MILP, ILP, MINLP, stochastic programming, chance-constrained models); metaheuristic and evolutionary algorithms (genetic algorithms, artificial bee colony, simulated annealing, grey wolf optimization); AI/ML-assisted scheduling (random forests, gradient boosting, latent class analysis, neural networks); logic-based decomposition and constraint programming (Answer Set Programming, Benders decomposition, binary decision diagrams); and real-time dynamic rescheduling systems (sensor-driven platforms, intelligent schedule boards, SaaS surgical workflow platforms).
- Mathematical programming (MILP, ILP, MINLP)
- Stochastic & robust optimization
- Metaheuristic & evolutionary algorithms
- AI/ML-assisted scheduling
- Real-time dynamic rescheduling
Four Innovation Clusters Shaping OR Scheduling
Patent filings and academic literature from 1997 to 2025 cluster into four distinct technical approaches, each addressing different aspects of the OR scheduling optimization problem.
Integer & Mixed-Integer Linear Programming
The dominant academic and early commercial approach uses ILP, MILP, and MINLP to formulate OR scheduling as a resource-constrained combinatorial problem. These models optimize OR utilization, overtime cost, patient waiting time, and blocking between perioperative stages. A 2020 study demonstrated a 64% average reduction in computational time versus prior MILP formulations. A 2023 MINLP model accounts for OR turnover and sterilization setup times across heterogeneous ORs. See also PatSnap Life Sciences solutions for healthcare IP analytics.
64% computational time reductionUncertainty Management Frameworks
A substantial cluster addresses inherent unpredictability of surgery durations, emergency arrivals, and bed availability through stochastic programming, robust optimization, chance-constrained models, and fuzzy methods. Duke University’s 2025 WO patent generates per-surgery-type mathematical distributions from historical data to bound resource consumption under uncertainty. A 2020 two-stage chance-constrained model controls overtime risk while minimizing OR opening and patient waiting costs. The PatSnap Analytics platform tracks stochastic IP clusters across jurisdictions.
Duke University WO 2025Genetic Algorithms, ABC & Grey Wolf Optimization
For large-scale instances where exact methods are computationally intractable, metaheuristics provide near-optimal solutions within practical time bounds. An improved genetic algorithm (IGA) demonstrated improved surgeon waiting time and OR idle time reduction for stochastic intraday scheduling (2021). A modified artificial bee colony (ABC) optimization was applied to a weekly open scheduling problem for up to 110 surgical cases (2021). The improved NSGA-II approach handles multi-objective cyclic surgical scheduling across specialties. Research from IEEE documents evolutionary algorithm advances for NP-hard scheduling.
Up to 110 surgical cases (ABC, 2021)Machine Learning, Sensor Integration & Autonomous Rescheduling
The most recent innovation cluster integrates machine learning for surgery duration prediction, real-time sensor monitoring, and autonomous schedule adjustment. IBM’s 2023 US patent collects multi-sensor intraoperative data to dynamically adjust subsequent OR schedules with notifications to care team participants. OSPITEK’s 2022 US patent employs ML to estimate procedure duration by procedure type, surgeon identity, and patient age. OPEXC’s 2025 US patent combines Monte Carlo simulations with probabilistic ML models across the full perioperative workflow. This cluster contains the highest concentration of active patent filings in this dataset.
Highest active filing concentrationPatent Assignee Landscape & Technology Distribution
Key assignees and technology cluster distributions from the OR scheduling optimization patent dataset (1997–2025).
Key Patent Assignees by Filing Activity
Active and pending OR-scheduling-specific patent filings per assignee, from the retrieved dataset. IBM, OSPITEK, and OPEXC lead in recent active filings.
Technology Cluster Relative Activity
Relative concentration of innovation activity per technology cluster in the OR scheduling dataset, with AI/ML carrying the highest active filing density.
Where OR Scheduling Optimization Is Being Deployed
The dataset spans six distinct hospital and surgical center application domains, from general multi-specialty hospitals to distributed multi-hospital networks.
Six Innovation Signals from 2023–2025 Filings
The most recent patent filings and literature in this dataset reveal six directional signals shaping the next generation of OR scheduling optimization technology.
Probabilistic & Sensor-Fused Case Mix Scheduling
DEO N.V.’s 2025 US filing integrates OR sensor data (intraoperative measurements) with patient parameters and procedure identifiers into scheduling models — a significant departure from purely historical or rule-based systems toward real-time feedback loops.
Per-Surgeon, Per-Procedure Mathematical Distribution Libraries
Duke University’s WO filing (2025) constructs scheduling distributions defined by surgery code, surgeon ID, and other attributes — enabling highly personalized scheduling accuracy beyond generic procedure-type averages and operationalizing latent class analysis at a systems level.
Monte Carlo & Stochastic Simulation-Based Perioperative Optimization
OPEXC INC.’s active US patent (2025) explicitly combines Monte Carlo simulations with probabilistic ML models across the full perioperative workflow, including estimated cancellation frequency and emergency OR forecasting — extending stochastic scheduling beyond surgery duration to encompass full demand-side uncertainty.
SaaS Platforms for End-to-End Surgical Workflow Coordination
GALA’s 2025 DE patent integrates pre-operative planning, real-time OR tracking, postoperative care monitoring, predictive analytics, and centralized communication into a single platform — representing the commercialization trajectory of previously fragmented optimization modules.
IP Strategy & R&D Positioning Signals
Key strategic observations for R&D teams, IP strategists, and product developers derived from the patent and literature landscape.
| Strategic Signal | Observation from Dataset | Implication |
|---|---|---|
| Prediction-then-optimization architecture | Most recent filings uniformly combine ML-based prediction (surgery duration, cancellation probability, emergency arrival) with downstream optimization engines | R&D teams should prioritize building high-quality per-surgeon, per-procedure historical data pipelines as the foundation for competitive advantage |
| Uncertainty modeling is now mandatory | Convergence of stochastic programming, chance-constrained models, robust optimization, and Monte Carlo simulation in recent literature signals deterministic models are academically and commercially obsolete | IP strategists should focus on defensible uncertainty handling architectures rather than core scheduling formulations, which are largely in the public domain |
| Real-time dynamic rescheduling is the commercial frontier | Highest concentration of live, commercially oriented filings (IBM 2023, OSPITEK 2022, OPEXC 2025, Stryker 2023) cluster around real-time monitoring and autonomous or semi-autonomous schedule adjustment | Sustainable commercial IP is being built in real-time rescheduling; this is where defensible differentiation resides |
| ICU/PACU/bed integration is a whitespace | Academic literature consistently identifies blocking between perioperative stages as a major efficiency driver; few commercial patent filings address ICU/PACU/bed availability as first-class optimization inputs | Defensible differentiation opportunity for product developers who integrate downstream resource constraints into commercial scheduling engines |
US Dominates, With Emerging Chinese Domestic IP
Among patent filings retrieved in this dataset, the US dominates with the majority of OR-scheduling-specific grants and applications. European jurisdictions (WO, NL, DE, EP) account for a secondary cluster, with notable contributions from Belgium (DEO N.V.) and Germany (Karl Storz). A single Chinese filing from 2025 signals emerging domestic innovation in China.
Academic literature contributions are geographically diverse, with significant output from Europe (Belgium, Italy, Netherlands, Spain, Norway, Turkey, South Korea) and North America. Innovation is distributed across academic medical centers (Duke University), medical device companies (Karl Storz, Stryker), technology incumbents (IBM), and healthcare software startups (OSPITEK, OPEXC, QUIVIQ).
Stryker Corporation is notable for two pending patent filings (US and EP, both 2023) on surgical workflow monitoring that interface with OR scheduling through real-time procedure progress tracking — representing the integration of medical device and scheduling technology. The WIPO PCT system has been used by Duke University (2025 WO) and DEO N.V. (2023 WO) to establish international priority. The EPO hosts Stryker’s EP filing. For competitive intelligence across these jurisdictions, see PatSnap Analytics.
The appearance of a 2025 CN pending filing from Sichuan Academy of Medical Sciences, combined with application domain literature citing Chinese day surgery centers, suggests Chinese hospital systems are beginning to generate domestic IP in this space. International market entrants should file PCT applications preemptively.
OR Scheduling Optimization — key questions answered
OR scheduling optimization uses mathematical programming (MILP, ILP, MINLP), metaheuristic algorithms (genetic algorithms, artificial bee colony, simulated annealing, grey wolf optimization), AI/ML-driven scheduling (random forests, gradient boosting, neural networks), and real-time dynamic rescheduling systems with sensor integration.
Among retrieved results, active patent holders include IBM (2023, US), OSPITEK INC. (2022, US), DEO N.V. (2025, US pending), OPEXC INC. (2025, US), Stryker Corporation (2023, US and EP), and Duke University (2025, WO). Karl Storz SE & Co. KG holds two active US patents from 2009 and 2013.
Machine learning is used to estimate surgery duration by procedure type, surgeon identity, and patient age; predict emergency arrival times; model cancellation frequency; and enable autonomous or semi-autonomous real-time schedule adjustment. IBM’s 2023 US patent collects multi-sensor intraoperative data to dynamically adjust subsequent OR schedules.
Stochastic programming, robust optimization, chance-constrained models, and Monte Carlo simulation are used to handle uncertain surgery durations, emergency arrivals, and bed availability. Duke University’s 2025 WO patent generates per-surgery-type mathematical distributions from historical data to bound resource consumption under uncertainty.
OR scheduling models must account for downstream resources including intensive care units (ICUs), post-anesthesia care units (PACUs), and hospital beds. Academic literature consistently identifies blocking between perioperative stages as a major efficiency driver, though few commercial patent filings address ICU/PACU/bed availability as first-class optimization inputs.
A 2020 paper on Mixed Integer Linear Programming Models for Scheduling Elective Surgical Procedures demonstrates a 64% average reduction in computational time versus prior MILP formulations.
PatSnap Eureka searches patents and research literature to answer instantly.